SureTrader
Nadex Advertisement
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Vascular Biogenics Ltd. (VBLT)

VBLT RSS Feed
Add VBLT Price Alert      Hide Sticky   Hide Intro
Moderator: gr8db8
Search This Board: 
Last Post: 7/21/2017 2:21:47 PM - Followers: 35 - Board type: Free - Posts Today: 0

Vascular Biogenics Ltd is an Israel-based clinical-stage biopharmaceutical company. The Company is engaged in the discovery, development and commercialization of treatments for cancer and immune-inflammatory diseases. Its clinical pipeline is based on two platform technologies that leverage the body’s natural physiologic and genetic regulatory elements. As of June 6, 2014, it has developed two programs based on these platforms an oncology program and an anti-inflammatory program. Its lead product candidate from its oncology program, VB-111, is a gene-based biologic that is initially developing for recurrent glioblastoma (rGBM), an aggressive form of brain cancer. The Company has also received orphan drug designation in both the United States and Europe. The Company’s oncology program is based on its Vascular Targeting System (VTS), platform technology, which utilizes genetically targeted therapy to destroy newly formed, or angiogenic, blood vessels. http://www.vblrx.com
VBLT
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
VBLT News: Report of Foreign Issuer (6-k) 06/22/2017 04:35:22 PM
VBLT News: Report of Foreign Issuer (6-k) 06/19/2017 04:34:03 PM
VBLT News: VBL Therapeutics Provides Update on Long-Term Survival in Phase 2 Trials of Patients with Multiple Tumor Types 06/19/2017 08:00:00 AM
VBLT News: VBL Therapeutics Announces Appointment of Dr. Corinne Epperly as U.S. Chief Operating Officer 06/15/2017 07:00:00 AM
VBLT News: VBL Therapeutics Awarded $2.5 Million Grant by the Israel Innovation Authority 06/08/2017 07:00:00 AM
PostSubject
#1096   Thoughts on the differences between median overall survival gr8db8 07/21/17 02:21:46 PM
#1095   Thanks for the share gr8. I imagine the wcopeland 07/17/17 07:53:36 PM
#1094   Notice the wording "a better planned randomized phase gr8db8 07/17/17 04:01:28 PM
#1093   I emailed him about my prospect about avastin. Oren1976 07/17/17 02:29:57 PM
#1092   Interesting comment from Cloughesy, who is leading the gr8db8 07/17/17 02:12:47 PM
#1091   Bottom line the interim will be a success. Oren1976 07/15/17 06:46:33 AM
#1090   Ok, so the notion on the forum is Lifeisawsome 07/14/17 08:32:52 PM
#1089   The way phase 2 worked, as I understand gr8db8 07/13/17 12:21:48 PM
#1088   You said the second cohort in ph2 suggests Oren1976 07/13/17 02:03:13 AM
#1087   This was my fear as well during my davidal66 07/13/17 12:22:43 AM
#1086   While we wait for the results, this deck gr8db8 07/12/17 05:44:55 PM
#1085   These mitochondrial effects are alarming. It can destroy Oren1976 07/12/17 05:29:11 PM
#1084   My fear is that the ph3 is not Oren1976 07/12/17 05:25:55 PM
#1083   I hear ya - there can be good gr8db8 07/12/17 04:36:12 PM
#1082   I skimmed the abstract for that paper the wcopeland 07/12/17 04:00:46 PM
#1081   oren ... more fuel for your "avastin devil" gr8db8 07/12/17 01:55:42 PM
#1080   Look at the charts from this new June Oren1976 07/08/17 12:54:28 AM
#1079   vbl preso from 6/28 gr8db8 07/07/17 05:11:17 PM
#1078   Avastin- the devil . Avastin educate the Oren1976 07/07/17 04:16:28 AM
#1077   I read that as him saying that he gr8db8 07/06/17 03:47:51 PM
#1076   Thanks understood now. They know probably the number Oren1976 07/05/17 11:43:33 PM
#1075   Doing the math, I can see why Dror gr8db8 07/05/17 03:20:03 PM
#1074   Dror gave the reason for his estimate and gr8db8 07/05/17 03:08:40 PM
#1073   "Because we were recruiting ahead of time, we Oren1976 07/05/17 12:28:08 PM
#1072   Are they blinded from number of death in Oren1976 07/05/17 12:17:35 PM
#1071   This is an interesting list. 3 on the gr8db8 06/28/17 03:42:10 PM
#1070   It doesn't work that way. I believe dror davidal66 06/26/17 07:17:50 PM
#1069   wcopeland, This Stock will be an interim result Valueinvestor12 06/26/17 02:38:09 PM
#1068   another important note from last conference call during Valueinvestor12 06/26/17 09:24:44 AM
#1067   I m against combo against buyout and against Oren1976 06/25/17 11:13:39 PM
#1066   1. That would be great if they paired wcopeland 06/25/17 12:46:17 PM
#1065   Thanks for digging that up value! So, second wcopeland 06/25/17 11:28:17 AM
#1064   I think mid Aug- Early Sept the company Valueinvestor12 06/24/17 11:44:26 PM
#1063   Thanks for that, Valueinvestor12. I think the key gr8db8 06/24/17 05:03:05 PM
#1062   wcopeland ... good post! My thoughts are: gr8db8 06/24/17 04:50:18 PM
#1061   from last conference call Dr. Dror said: Valueinvestor12 06/24/17 04:14:02 PM
#1060   My guess: Second half of Q3, so mid-August wcopeland 06/24/17 10:56:27 AM
#1059   Your guess interim ? I think only q4 Oren1976 06/23/17 11:08:36 PM
#1058   They will choose the safest for lung cancer. Oren1976 06/22/17 07:34:20 PM
#1057   Dror has said several times now that they wcopeland 06/22/17 05:12:09 PM
#1056   Interesting development on an oncoprotein GT198, which these gr8db8 06/20/17 01:00:08 PM
#1055   More from the same session: gr8db8 06/19/17 06:20:42 PM
#1054   Insight on Epperly. Here's a snippet on her gr8db8 06/19/17 05:25:10 PM
#1053   Interesting the figure 50% achieved long term while Oren1976 06/19/17 01:03:14 PM
#1052   Intriguing indeed Like the risk/reward here mjw007 06/19/17 12:31:06 PM
#1051   The data is intriguing: "in all three indications gr8db8 06/19/17 12:19:58 PM
#1050   Clearly do not understand this market cap mjw007 06/19/17 09:34:55 AM
#1049   Also, news came out that Trump is going wcopeland 06/19/17 09:30:23 AM
#1048   1. Clearly market is loving the news so far. wcopeland 06/19/17 09:27:09 AM
#1047   Soon we know. They have a potential cure Oren1976 06/19/17 09:22:59 AM
PostSubject